Nichols Weston's Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed Jun 2, 2023
- Accession no.
- 0000902664-23-003407
- Filed
- Jun 2, 2023, 5:35 PM ET
- Trade date
- May 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $64.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Common stock, $0.0001 par value per share Common Stock | SSaleDisposed | −10,000 | $2.51 | −$25,148 | 5,240,000 | Indirect | |
| May 31, 2023 | Common Stock | SSaleDisposed | −15,000 | $2.52 | −$37,801.5 | 5,225,000 | Indirect | |
| May 31, 2023 | Common Stock | SSaleDisposed | −400 | $2.51 | −$1,003 | 5,224,600 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.